Notable Stock Analysts Ratings: CytRx Corporation (NASDAQ:CYTR)

0
72

CytRx Corporation (NASDAQ:CYTR) reported the earnings of $-0.13/Share in the last quarter where the estimated EPS by analysts was $-0.13/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for CytRx Corporation and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.11/share. These analysts have also projected a Low Estimate of $-0.11/share and a High Estimate of $-0.11/share.

Some buy side analysts are also providing their Analysis on CytRx Corporation, where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 1 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for CytRx Corporation might touch $10 high while the Average Price Target and Low price Target is $4.58 and $0.75 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. CytRx Corporation got Initiated on 7-Jan-16 where investment firm Jefferies Initiated the stock to Hold.

CytRx Corporation closed its last trading session at $0.56 with the gain of 1.77%. The Market Capitalization of the company stands at 55.27 Million. The Company has 52-week high of $3.66 and 52-week low of $0.41. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 12.96% where SMA50 and SMA200 are 8.64% and -65.33% respectively. The Company Touched its 52-Week High on Apr 25, 2016 and 52-Week Low on Nov 4, 2016.

The Relative Volume of the company is 15.37 and Average Volume (3 months) is 878.33 million. CytRx Corporation P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -98.1%. The Return on Equity (ROE) value stands at -209.9%. While it’s Return on Investment (ROI) value is -143.5%.

While looking at the Stock’s Performance, CytRx Corporation currently shows a Weekly Performance of -1.74%, where Monthly Performance is 18.73%, Quarterly performance is -1.74%, 6 Months performance is -80.55% and yearly performance percentage is -81.79%. Year to Date performance value (YTD perf) value is -78.49%. The Stock currently has a Weekly Volatility of 10.51% and Monthly Volatility of 9.13%.